[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 18, Issue 3 (10-2016) ::
J Gorgan Univ Med Sci 2016, 18(3): 40-44 Back to browse issues page
Additive effects of trans-resveratrol and imipramine to reduce depressive symptoms in the forced swimming test in mice
R Ataee 1, AH Gitinavard2 , A Ataie3 , Y Nourian4 , M Shaterpour4
1- Assistant Professor, Talasemia Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran & Assistant Professor, Pharmaceutical Sciences Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran. , raminataee1349@gmail.com
2- Pharmacy Studen, Pharmaceutical Sciences Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran.
3- Assistant Professor, Department of Physiology and Pharmacology, Babol Universityof Medical Sciences, Babol, Iran.
4- M.Sc Student of Toxicology, Pharmaceutical Sciences Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran.
Abstract:   (8804 Views)

Background and Objective: Resveratrol is a phenolic herbal compound which has been proposed as antioxidant in combinational therapy of diabetes, cancer and some neurodegenerative diseases. This study was done to evaluate additive effect of trans-resveratrol and imipramine to reduce depressive symptoms in the forced swimming test in mice.

Methods: In this experimental study, 56 Swiss Webster male mice were randomly allocated into 6 groups including negative control group (normal saline), positive control (imipramine (10 mg/kg/bw), experimental groups; trans resveratrol (10 mg/kg/bw), Imipiramine (10 mg/kg/bw) and mixtures (with ratio of 1:1 of resveratrol with imipramine (2.5 mg/kg/bw, 5 and 10 mg/kg/bw), intraperitoneally. The forced swimming test has been done for all groups. Through swimming of animals in water, the immobilization times of animals as depressive symptom were recorded.

Results: The immobilization times significantly reduced in animals which were received imipramine
10 mg/kg/bw in compare to control group (P<0.05). The immobilization times of animals were received resveratrol injection 10 mg/kg/bw with imipramine 10 mg/kg/bw was determined which it was significantly effective than imipramine10 mg/kg/bw, alone (P<0.05). The antidepressant effectiveness of resveratrol injection 5 mg/kg/bw is similar to resveratrol (2.5 mg/kg/bw) with imipramine (2.5mg/kg/bw). is similar to resveratrol (2.5 mg/kg) with imipramine (2.5 mg/kg/bw) (P<0.05). Also, antidepressant effect of intraperitoneal administration of resveratrol 10 mg/kg was significantly more than imipramine
10 mg/kg/bw (P<0.05).

Conclusion: According to additive effect of imipramine with resveratrol we can suggest resveratrol in combinations with other antidepressants to lower their doses and related side effects of chemical drugs.

Keywords: Depression, Resveratrol, Imipramine, Forced swimming test, Mouse
Full-Text [PDF 185 kb] [English Abstract]   (11165 Downloads) |   |   Abstract (HTML)  (1024 Views)  
Type of Study: Original Articles | Subject: Physiology - Pharmacology
References
1. Baldessarini RJ. Depression and Mania. In: Brunton L, Chabner B, Knollman B. Goodman and Gilman's the Pharmacological Basis of therapeutics. 20th ed. New York: Mc Graw Hill. 2001; pp: 431-59.
2. Carvalho AF, Berk M, Hyphantis TN, McIntyre RS. The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom. 2014; 83(2): 70-88. doi: 10.1159/000357500
3. Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav. 2013; 118: 227-39. doi: 10.1016/j.physbeh.2013.05.012
4. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002 Dec; 958(2): 439-47.
5. Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM, et al. Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci. 2011 Jan; 1215:103-8. doi: 10.1111/j.1749-6632.2010.05865.x
6. Jacobson JM. The relationship between social support and depression in adolescents. J Child Adolesc Psychiatr Nurs. 1991 Jan; 4(1): 20-24. doi: 10.1111/j.1744-6171.1991.tb00481.x
7. Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, et al. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol. 2010 Jun; 20(6):405-13. doi: 10.1016/j.euroneuro.2010.02.013
8. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl). 2008 Dec;201(3):435-42. doi: 10.1007/s00213-008-1300-y
9. Kulkarni S, Dhir A, Akula KK. Potentials of curcumin as an antidepressant. Scientific World Journal. 2009 Nov; 9:1233-41. doi: 10.1100/tsw.2009.137
10. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol. 2005 Jul; 518(1):40-6.
11. Yu Y, Wang R, Chen C, Du X, Ruan L, Sun J, et al. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences. J Psychiatr Res. 2013 Mar; 47(3):315-22. doi: 10.1016/j.jpsychires.2012.10.018
12. Huang W, Chen Z, Wang Q, Lin M, Wu S, Yan Q, et al. Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. Metab Brain Dis. 2013 Dec; 28(4):585-95. doi: 10.1007/s11011-013-9426-y
13. Wang Z, Gu J, Wang X, Xie K, Luan Q, Wan N, et al. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol Biochem Behav. 2013 Nov; 112:104-10. doi: 10.1016/j.pbb.2013.10.007
14. Huang J, Tufan T, Deng M, Wright G, Zhu MY. Corticotropin releasing factor up-regulates the expression and function of norepinephrine transporter in SK-N-BE (2) M17 cells. J Neurochem. 2015 Oct; 135(1):38-49. doi: 10.1111/jnc.13268
15. Satoh N, Toyohira Y, Takahashi K, Yanagihara N. Effects of various pharmacological agents on the function of norepinephrine transporter. J UOEH. 2015 Mar; 37(1):33-42. doi: 10.7888/juoeh.37.33
16. Matchkov VV, Kravtsova VV, Wiborg O, Aalkjaer C, Bouzinova EV. Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. Am J Physiol Regul Integr Comp Physiol. 2015 Oct; 309(8):R814-23. doi: 10.1152/ajpregu.00337.2014
17. Ge L, Zhu MM, Yang JY, Wang F, Zhang R, Zhang JH, et al. Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. Pharmacol Biochem Behav. 2015 Apr; 131:77-86. doi: 10.1016/j. pbb.2015.01.017
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ataee R, Gitinavard A, Ataie A, Nourian Y, Shaterpour M. Additive effects of trans-resveratrol and imipramine to reduce depressive symptoms in the forced swimming test in mice. J Gorgan Univ Med Sci 2016; 18 (3) :40-44
URL: http://goums.ac.ir/journal/article-1-2835-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 3 (10-2016) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4645